Arrow Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Arrow Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,000	Closed	-$51K	–	340
2021 Q3	$51K	Hold	14,000	–	–	0.01%	213
2021 Q2	$61K	Hold	14,000	–	–	0.01%	203
2021 Q1	$58K	Hold	14,000	–	–	0.01%	204
2020 Q4	$56K	Hold	14,000	–	–	0.01%	194
2020 Q3	$38K	Hold	14,000	–	–	0.01%	206
2020 Q2	$39K	Hold	14,000	–	–	0.01%	214
2020 Q1	$33K	Hold	14,000	–	–	0.01%	227
2019 Q4	$66K	Hold	14,000	–	–	0.01%	202
2019 Q3	$47K	Hold	14,000	–	–	0.01%	220
2019 Q2	$46K	Hold	14,000	–	–	0.01%	230
2019 Q1	$42K	Hold	14,000	–	–	0.01%	229
2018 Q4	$38K	Hold	14,000	–	–	0.01%	222
2018 Q3	$47K	Buy	+14,000	New	+$43.2K	0.01%	225

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Arrow Financial's ATRS Position: Q4 2021 in Review

Arrow Financial sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 14,000 shares — an estimated $51K sold.

Arrow Financial first reported a position in ATRS in Q3 2018 and held it in 13 quarters. The position peaked at $66K in Q4 2019. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

Arrow Financial reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
Arrow Financial sold 14,000 Antares Pharma, Inc. shares in Q4 2021, an estimated $51K.
Arrow Financial first reported a position in Antares Pharma, Inc. in Q3 2018 and held it in 13 quarters.
Arrow Financial's Antares Pharma, Inc. position peaked at $66K in Q4 2019.
162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Arrow Financial's 13F filing for Q4 2021, filed 28 Jan 2022.